2,5-di-tert-butylhydroquinone has been researched along with dactinomycin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikebuchi, H; Onose, J; Sawada, J; Teshima, R | 1 |
| Onose, J; Sawada, J; Teshima, R | 1 |
| Okunuki, H; Onose, J; Sawada, J; Teshima, R | 1 |
3 other study(ies) available for 2,5-di-tert-butylhydroquinone and dactinomycin
| Article | Year |
|---|---|
Ca2+-ATPase inhibitors and PKC activation synergistically stimulate TNF-alpha production in RBL-2H3 cells.
Topics: Animals; Calcium-Transporting ATPases; Dactinomycin; Dexamethasone; Enzyme Activation; Enzyme Inhibitors; Hydroquinones; Indoles; Leukemia, Basophilic, Acute; Protein Kinase C; Rats; Tacrolimus; Thapsigargin; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1998 |
Ca2+-ATPase inhibitor induces IL-4 and MCP-1 production in RBL-2H3 cells.
Topics: Animals; Antioxidants; Calcium-Transporting ATPases; Chemokine CCL2; Dactinomycin; Dose-Response Relationship, Drug; Hydroquinones; Indoles; Interleukin-4; Mast Cells; Rats; Tacrolimus; Tetradecanoylphorbol Acetate; Time Factors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1998 |
Effect of Ca(2+) ATPase inhibitors on MCP-1 release from bone marrow-derived mast cells and the involvement of p38 MAP kinase activation.
Topics: Animals; Blotting, Western; Bone Marrow Cells; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Calcium-Transporting ATPases; Chemokine CCL2; Cyclosporine; Dactinomycin; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Inhibitors; Female; Hydroquinones; Indoles; Mast Cells; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2000 |